Paul Hartmann AG PHH2
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €201.00
- Day Range
- €201.00–201.00
- 52-Week Range
- €178.50–—
- Bid/Ask
- €0.00 / €0.00
- Market Cap
- €713.90 Mil
- Volume/Avg
- 0 / —
Key Statistics
- Price/Earnings (Normalized)
- 24.31
- Price/Sales
- 0.30
- Dividend Yield (Trailing)
- 3.98%
- Dividend Yield (Forward)
- 3.98%
- Total Yield
- 3.98%
Company Profile
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 10,168
- Website
- http://www.hartmann.info
Comparables
Valuation
|
Metric
|
PHH2
|
603301
|
VBSN
|
|---|---|---|---|
Price/Earnings (Normalized) | 24.31 | 20.44 | 20.35 |
Price/Book Value | 0.67 | 0.99 | 2.06 |
Price/Sales | 0.30 | 1.43 | 2.11 |
Price/Cash Flow | 4.52 | 7.94 | 15.66 |
Price/Earnings
PHH2
603301
VBSN
Financial Strength
|
Metric
|
PHH2
|
603301
|
VBSN
|
|---|---|---|---|
Quick Ratio | 1.16 | 1.77 | 3.89 |
Current Ratio | 2.12 | 2.46 | 4.42 |
Interest Coverage | 3.98 | 3.93 | 887.05 |
Quick Ratio
PHH2
603301
VBSN
Profitability
|
Metric
|
PHH2
|
603301
|
VBSN
|
|---|---|---|---|
Return on Assets (Normalized) | 1.72% | 1.57% | 8.59% |
Return on Equity (Normalized) | 3.22% | 2.23% | 10.63% |
Return on Invested Capital (Normalized) | 3.20% | 1.68% | 9.97% |
Return on Assets
PHH2
603301
VBSN
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| Chgpkzwqp | Rpdx | $151.0 Bil | |||
| Becton Dickinson & Co
BDX
| Vzjmpsj | Szjwc | $67.5 Bil | |||
| Alcon Inc
ALC
| Rrgdxpz | Bjzjmx | $44.4 Bil | |||
| ResMed Inc
RMD
| Nnxnptsx | Tpdkhm | $31.1 Bil | |||
| Coloplast A/S ADR
CLPBY
| Xdngrdnjbx | Zjyp | $27.6 Bil | |||
| West Pharmaceutical Services Inc
WST
| Hnxxnmjnv | Tbsrz | $24.4 Bil | |||
| The Cooper Companies Inc
COO
| Jmkztshdm | Kzdddf | $18.6 Bil | |||
| Baxter International Inc
BAX
| Fcnhqqxf | Srlks | $17.2 Bil | |||
| Hologic Inc
HOLX
| Vjzpkrk | Xjyxmz | $16.8 Bil | |||
| Teleflex Inc
TFX
| Tlf | Vglvd | $9.8 Bil |